Methyl alpha-[3-hydroxy4-(1-oxopropyl)-2,6-dipropylphenoxy]benzeneacetate | 449779-74-2

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Methyl alpha-[3-hydroxy4-(1-oxopropyl)-2,6-dipropylphenoxy]benzeneacetate
• 英文别名: methyl 2-(3-hydroxy-4-propanoyl-2,6-dipropylphenoxy)-2-phenylacetate
• CAS: 449779-74-2
• 化学式: C₂₄H₃₀O₅
• 分子量: 398.499
• InChiKey: MVONTERZQYNTLC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.5
• 重原子数：
  29
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  Methyl alpha-[3-hydroxy4-(1-oxopropyl)-2,6-dipropylphenoxy]benzeneacetate 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 以64%的产率得到(3-Hydroxy-4-propionyl-2,6-dipropyl-phenoxy)-phenyl-acetic acid
  参考文献：
  名称：

  O-Arylmandelic acids as highly selective human PPAR α/γ agonists

  摘要：

  A new class of O-arylmandelic acid PPAR agonists show excellent anti-hyperglycemic efficacy in a db/db mouse model of DM2. These PPARalpha-weighted agonists do not show the typical PPARgamma associated side effects of BAT proliferation and cardiac hypertrophy in a rat tolerability assay. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00702-9
• 作为产物：
  描述：

  2,4-di-n-propylbenzene-1,3-diol 在 三氟甲磺酸 、 caesium carbonate 作用下， 生成 Methyl alpha-[3-hydroxy4-(1-oxopropyl)-2,6-dipropylphenoxy]benzeneacetate
  参考文献：
  名称：

  O-Arylmandelic acids as highly selective human PPAR α/γ agonists

  摘要：

  A new class of O-arylmandelic acid PPAR agonists show excellent anti-hyperglycemic efficacy in a db/db mouse model of DM2. These PPARalpha-weighted agonists do not show the typical PPARgamma associated side effects of BAT proliferation and cardiac hypertrophy in a rat tolerability assay. (C) 2003 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(03)00702-9

文献信息

• 2-Aryloxy-2arylalkanoic acids for diabetes and lipid disorders
  申请人：——

  公开号：US20040092596A1

  公开（公告）日：2004-05-13

  A class of 2-aryloxy-2-arylalkanoic acids comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.

  一类2-芳氧基-2-芳基脂肪酸是PPAR alpha和/或gamma的有效激动剂，因此可用于治疗、控制或预防非胰岛素依赖性糖尿病（NIDDM）、高血糖、脂质代谢异常、高脂血症、高胆固醇血症、高三酰甘油血症、动脉粥样硬化、肥胖症、血管再狭窄、炎症和其他PPAR alpha和/或gamma介导的疾病、疾病和病况。
• 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
  申请人：Adams D. Alan

  公开号：US20060122242A1

  公开（公告）日：2006-06-08

  A class of 2-aryloxy-2-arylalkanoic acids comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.

  一类2-芳氧基-2-芳基脂肪酸是一种强效PPAR alpha和/或gamma激动剂，因此可用于治疗、控制或预防非胰岛素依赖性糖尿病（NIDDM）、高血糖、失调脂质代谢、高脂血症、高胆固醇血症、高三酰甘油血症、动脉粥样硬化、肥胖症、血管再狭窄、炎症和其他PPAR alpha和/或gamma介导的疾病、疾病和状况。
• 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
  申请人：Merck & Co., Inc.

  公开号：US07495020B2

  公开（公告）日：2009-02-24

  A class of 2-aryloxy-2-arylalkanoic acids comprises compounds that are potent agonists of PPAR alpha and/or gamma, and are therefore useful in the treatment, control or prevention of non-insulin dependent diabetes mellitus (NIDDM), hyperglycemia, dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, atherosclerosis, obesity, vascular restenosis, inflammation, and other PPAR alpha and/or gamma mediated diseases, disorders and conditions.

  一类2-芳氧基-2-芳基烷基酸包括化合物，它们是PPARα和/或γ的有效激动剂，因此可用于治疗、控制或预防非胰岛素依赖性糖尿病（NIDDM）、高血糖、脂质代谢异常、高血脂、高胆固醇血症、高三酰甘油血症、动脉粥样硬化、肥胖症、血管再狭窄、炎症和其他PPARα和/或γ介导的疾病、疾患和状况的治疗。
• US7091230B2
  申请人：——

  公开号：US7091230B2

  公开（公告）日：2006-08-15
• US7495020B2
  申请人：——

  公开号：US7495020B2

  公开（公告）日：2009-02-24